Jefferies Group's LUNG Position Overview
Jefferies Group (via Jefferies Financial Group Inc.) currently holds 285,110 shares of Pulmonx Corporation (LUNG) worth $367,792, representing 0.00% of the portfolio. First purchased in 2022-Q4, this medium-term investment has been held for 14 quarters.
Based on 13F filings, Jefferies Group has maintained a strategic position in LUNG, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2024, adding 50,000 shares. Largest reduction occurred in Q1 2024, reducing 50,000 shares.
Analysis based on 13F filings available since 2013 Q2
Jefferies Group's Pulmonx Corporation (LUNG) Holding Value Over Time
Track share changes against reported price movement
Quarterly Pulmonx Corporation (LUNG) Trades by Jefferies Group
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2024 | -1,206 | Reduce 0.42% | 285,110 | $6.79 |
| Q3 2024 | +1,206 | Add 0.42% | 286,316 | $8.29 |
| Q2 2024 | +50,000 | Add 21.27% | 285,110 | $6.34 |
| Q1 2024 | -50,000 | Reduce 17.54% | 235,110 | $9.27 |
| Q2 2023 | -10 | Reduce 0.00% | 285,110 | $13.11 |
| Q1 2023 | +10 | Add 0.00% | 285,120 | $11.18 |
| Q4 2022 | +285,110 | New Buy | 285,110 | $8.43 |
Jefferies Group's Pulmonx Corporation Investment FAQs
Jefferies Group first purchased Pulmonx Corporation (LUNG) in Q4 2022, acquiring 285,110 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jefferies Group has held Pulmonx Corporation (LUNG) for 14 quarters since Q4 2022.
Jefferies Group's largest addition to Pulmonx Corporation (LUNG) was in Q4 2022, adding 285,110 shares worth $2.4 M.
According to the latest 13F filing for Q1 2026, Jefferies Group's firm, Jefferies Financial Group Inc., owns 285,110 shares of Pulmonx Corporation (LUNG), valued at approximately $367,792.
As of the Q1 2026 filing, Pulmonx Corporation (LUNG) represents approximately 0.00% of Jefferies Group's publicly disclosed stock portfolio, making it one of their key holdings.
Jefferies Group's peak holding in Pulmonx Corporation (LUNG) was 286,316 shares, as reported at the end of Q3 2024.